Enfortumab vedotin induces immunogenic cell death and shows enhanced preclinical antitumor activity when combined with a PD-1 inhibitor. (linkinghub.elsevier.com)

Authors: Olson DJ … Sandall S Journal: Cell Reports Medicine Published: 2026-09-02 DOI: https://doi.org/10.1016/j.xcrm.2026.103021